Yazan Ayman Abuzenah
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yazan Ayman Abuzenah has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Asaad Mohammad Jarrar
Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan
1 shared publication - Mohammad Alathirah
Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan
1 shared publication - Mohammad Tayyem
Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan
1 shared publication - Reem Mohammad Muhsen
Department of General Surgery and Urology, Faculty of Medicine, The Jordan University of Science and Technology
1 shared publication - Rola Saqan
Pediatric Department, Jordan University of Science and Technology, Irbid, Jordan
1 shared publication Wail Hayajneh
Pediatric Infectious Diseases, Cardinal Glennon Children’s Medical Center, St Louis, MO, USA
1 shared publication
Latest Publications
- Open Access
- 1 March 2026
- Published by Taylor & Francis in Infection and Drug Resistance
- Vol. ume 19, 1-8
Prevalence of Urinary Tract Infections Caused by Extended-Spectrum β-Lactamase Escherichia coli, a Tertiary Center Nine-Year Comparison
Purpose: This study used data collected nine years apart (2014 and 2023) to compare the prevalence of Escherichia coli that produces extended-spectrum β-lactamase (ESBL) among patients with urinary tract infections at a tertiary care center. Additionally, it aimed to assess how ESBL prevalence varied by gender and age group. Patients and Methods: Urine culture data from 2014 and 2023 were used in this two-point cross-sectional investigation. Data on demographics and microbiology were retrieved and examined. Chi-square tests were used in conjunction with prevalence ratios and phi coefficient tests for statistical comparison. Results: The overall prevalence of ESBL-positive E. coli in 2500 patients rose from 43.7% to 58.9% between 2014 and 2023. The rise was even more noticeable in male patients PR = 1.50 and pediatric patients 41% to 65.4%, PR = 1.55. All age groups showed statistically significant increases in ESBL-positive, however, the level of statistical power varied. Conclusion: There has been a rise in ESBL-producing E. coli UTIs over the previous ten years, particularly in male children. These results emphasize how urgent it is to improve responsible antibiotic use must be improved to reduce future antimicrobial resistance.
- 1 March 2026
- Published by Taylor & Francis in Infection and Drug Resistance
- Vol. ume 19, 1-8
Open AccessPrevalence of Urinary Tract Infections Caused by Extended-Spectrum β-Lactamase Escherichia coli, a Tertiary Center Nine-Year Comparison
Purpose: This study used data collected nine years apart (2014 and 2023) to compare the prevalence of Escherichia coli that produces extended-spectrum β-lactamase (ESBL) among patients with urinary tract infections at a tertiary care center. Additionally, it aimed to assess how ESBL prevalence varied by gender and age group. Patients and Methods: Urine culture data from 2014 and 2023 were used in this two-point cross-sectional investigation. Data on demographics and microbiology were retrieved and examined. Chi-square tests were used in conjunction with prevalence ratios and phi coefficient tests for statistical comparison. Results: The overall prevalence of ESBL-positive E. coli in 2500 patients rose from 43.7% to 58.9% between 2014 and 2023. The rise was even more noticeable in male patients PR = 1.50 and pediatric patients 41% to 65.4%, PR = 1.55. All age groups showed statistically significant increases in ESBL-positive, however, the level of statistical power varied. Conclusion: There has been a rise in ESBL-producing E. coli UTIs over the previous ten years, particularly in male children. These results emphasize how urgent it is to improve responsible antibiotic use must be improved to reduce future antimicrobial resistance.